Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03909282 · ClinicalTrials.gov registry record · NA
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
A NA study of Ductal Breast Carcinoma in Situ, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03909282: Recruiting NA study of Ductal Breast Carcinoma in Situ, sponsored by Stanford University.
NCT03909282 is a NA study of Ductal Breast Carcinoma in Situ that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 147-participant average among 11 other Ductal Breast Carcinoma in Situ trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03909282, a NA study of Ductal Breast Carcinoma in Situ, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to compare by pathological findings surgical excision versus neoadjuvant radiotherapy followed by delayed surgical excision of ductal carcinoma in situ (DCIS)
Primary Outcome
A DCIS pathologic complete response will be defined as the absence of in situ carcinoma in the surgical resection specimen. The rate of DCIS pathologic complete response (pCR) will be calculated for Arm 1 and Arm 2.
Conditions Studied
Interventions
- PROCEDURE Lumpectomy
- RADIATION Partial breast irradiation prior to surgery
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT03909282 shows while recruiting
NCT03909282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 147-participant average among 11 other Ductal Breast Carcinoma in Situ trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Ductal Breast Carcinoma in Situ appearing as the primary indexed condition, and to 2 interventions - of which Lumpectomy is the first listed.
NCT03909282 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03909282 about?
NCT03909282 is a clinical study titled "Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma". The purpose of this pilot study is to compare by pathological findings surgical excision versus neoadjuvant radiotherapy followed by delayed surgical excision of ductal carcinoma in situ (DCIS)
What is the current status of trial NCT03909282?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-03-22. Estimated completion is 2026-12.
What conditions does trial NCT03909282 study?
This clinical trial studies the following conditions: Ductal Breast Carcinoma in Situ.
What interventions are being tested in trial NCT03909282?
The interventions under investigation include: Lumpectomy (PROCEDURE), Partial breast irradiation prior to surgery (RADIATION).
Who is sponsoring clinical trial NCT03909282?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03909282 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ductal Breast Carcinoma in Situ
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03909282's enrollment target sits among peer trials
50 11th of 11 higher than 1 of 11 other Ductal Breast Carcinoma in Situ trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ductal Breast Carcinoma in Situ trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
ACTIVE NOT RECRUITING · NA
-
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
ACTIVE NOT RECRUITING · NA
-
Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
ACTIVE NOT RECRUITING · NA
-
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
RECRUITING · Phase 2
-
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
ACTIVE NOT RECRUITING · Phase 3
-
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI